Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease

Clinical trial NCT04412395 · UNKNOWN

Trial details

NCT number: NCT04412395
Sponsor: National Research Centre, Egypt
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Corona Virus Infection Middle East Respiratory Syndrome (MERS)Acute Respiratory Distress Syndrome Coronavirus Infection COVID-19 SARS-CoV 2

Start date: 2022-02-01
Primary completion: 2022-08-01
Enrollment: 516

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.